Differentiating hepatic hemangiomas from hepatocellular carcinomas using Sonazoid-enhanced ultrasonography: a proposed two-step diagnostic algorithm
Open Access
- 1 September 2026
- journal article
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 45 (5) , 491-502
Abstract
Purpose: This study aimed to develop a diagnostic algorithm for differentiating hepatic hemangiomas from hepatocellular carcinoma (HCC) using Sonazoid-enhanced ultrasonography (SEUS).Methods: A retrospective analysis was conducted of SEUS examinations from 159 patients with 110 hemangiomas and 49 HCCs between January 2011 and December 2022. The evaluated imaging features included lesion hyperechogenicity, typical grayscale features of hemangioma, defined as a hyperechoic lesion or echogenic border without a hypoechoic rim or nodule-in-nodule appearance, and typical globular enhancement of hemangioma. In the Kupffer phase (KP), the lesion-to-liver ratio (KP ratio) was calculated, and receiver operating characteristic analysis was performed to determine the optimal KP ratio cutoff for predicting hemangioma. A two-step diagnostic algorithm was developed and compared with typical globular enhancement of hemangioma using the McNemar test.Results: The optimal KP ratio cutoff for predicting hemangioma was 0.85. The two-step algorithm first identified hemangiomas based on typical globular enhancement and then applied typical grayscale features and a KP ratio ≥0.85 to lesions without typical globular enhancement. The algorithm showed higher sensitivity than typical globular enhancement alone (90.0% vs. 81.8%, P=0.008) while maintaining 100% specificity. In hyperechoic lesions, the algorithm also showed higher sensitivity than typical globular enhancement alone (91.9% vs. 77.4%, P=0.008).Conclusion: The proposed two-step algorithm may improve sensitivity while maintaining specificity in clinical settings that require differentiation between hemangiomas and HCC.Keywords
This publication has 22 references indexed in Scilit:
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic reviewHepatology, 2023
- Recognizing the Role of the Reticuloendothelial System in the Late Phase of US Contrast AgentsRadiology, 2021
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2020
- Introduction: 4th Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver—Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM and FLAUSUltrasound in Medicine & Biology, 2020
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- Integration of Contrast-enhanced US into a Multimodality Approach to Imaging of Nodules in a Cirrhotic Liver: How I Do ItRadiology, 2017
- Kupffer-Phase Findings of Hepatic Hemangiomas in Contrast-Enhanced Ultrasound with SonazoidUltrasound in Medicine & Biology, 2014
- Contrast‐enhanced sonography in the diagnosis of hepatic hemangiomas: Atypical appearance due to the washout of microbubblesJournal of Clinical Ultrasound, 2012
- Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, SonazoidIntervirology, 2008
- Fatty Liver: Imaging Patterns and PitfallsRadioGraphics, 2006